Changes in blood metabolomes as potential biomarkers for severity and prognosis in doxorubicin-induced heart failure: a study in HER2-positive and HER2-negative breast cancer patients
Event: ESC Congress 2024
Topic: Cardiotoxicity of Drugs and Other Therapies
Session: Cardiomyopathies uncovered
